Search Result "M244V"
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan
De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 33 Year: 2016 Page: 5057-5064
Author(s): Washington Pereira,Ihosvany Camps
Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar
Molecular Dynamic Studies Unveil Potential Mechanisms of Resistance to Imatinib in BCR-ABL Mutants
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Tai-Sung Lee,Steven J. Potts,Maher Albitar
Doi: 10.2174/9781608059089114030011
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Journal: Current Drug Metabolism
Volume: 18 Issue: 3 Year: 2017 Page: 199-206
Author(s): Ruiqing Wang,Chaoqin Zhong,Chen Zhang,Mingqiang Hua,Daoxin Ma
Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura
Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 4 Year: 2019 Page: 333-345
Author(s): Vivek Kumar Singh,Mohane Selvaraj Coumar
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 391-401
Author(s): M. Breccia,G. Alimena
Dasatinib in the Treatment of Chronic Myeloid Leukemia
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 99-105
Author(s): Joanna Gora-Tybor, Tadeusz Robak